1-[(2R)-2-amino-3-(4-cyanophenyl)propanoyl]-5-naphthalen-1-yl-3,6-dihydro-2H-pyridine-4-carbonitrile | 570396-96-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1-[(2R)-2-amino-3-(4-cyanophenyl)propanoyl]-5-naphthalen-1-yl-3,6-dihydro-2H-pyridine-4-carbonitrile
• CAS: 570396-96-2
• 化学式: C₂₆H₂₂N₄O
• 分子量: 406.487
• InChiKey: KJHFEIWKXCOOSA-RUZDIDTESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  31
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  93.9
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-甲基-1氢-5-醛基-咪唑 、 1-[(2R)-2-amino-3-(4-cyanophenyl)propanoyl]-5-naphthalen-1-yl-3,6-dihydro-2H-pyridine-4-carbonitrile 在 sodium cyanoborohydride 作用下， 以81%的产率得到1-[(2R)-3-(4-cyanophenyl)-2-{[(1-methyl-1H-imidazol-5-yl)methyl]amino}propanoyl]-5-(naphthalen-1-yl)-1,2,3,6-tetrahydropyridine-4-carbonitrile
  参考文献：
  名称：

  Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives

  摘要：

  Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered a series of aryl tetrahydropyridines that incorporate substituted glycine, phenylalanine and histidine residues. The design, synthesis, SAR and biological properties of these compounds will be discussed. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00095-7
• 作为产物：
  描述：

  3-氯-4-氰基吡啶 在 盐酸 、 1-氯乙基氯甲酸酯 、 sodium cyanoborohydride 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 生成 1-[(2R)-2-amino-3-(4-cyanophenyl)propanoyl]-5-naphthalen-1-yl-3,6-dihydro-2H-pyridine-4-carbonitrile
  参考文献：
  名称：

  Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives

  摘要：

  Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered a series of aryl tetrahydropyridines that incorporate substituted glycine, phenylalanine and histidine residues. The design, synthesis, SAR and biological properties of these compounds will be discussed. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00095-7

文献信息

• Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives
  作者：Stephen L. Gwaltney、Stephen J. O'Connor、Lissa T.J. Nelson、Gerard M. Sullivan、Hovis Imade、Weibo Wang、Lisa Hasvold、Qun Li、Jerome Cohen、Wen-Zhen Gu、Stephen K. Tahir、Joy Bauch、Kennan Marsh、Shi-Chung Ng、David J. Frost、Haiying Zhang、Steve Muchmore、Clarissa G. Jakob、Vincent Stoll、Charles Hutchins、Saul H. Rosenberg、Hing L. Sham

  DOI：10.1016/s0960-894x(03)00095-7

  日期：2003.4

  Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered a series of aryl tetrahydropyridines that incorporate substituted glycine, phenylalanine and histidine residues. The design, synthesis, SAR and biological properties of these compounds will be discussed. (C) 2003 Elsevier Science Ltd. All rights reserved.